Purchases and Sales Made in Q4 2022 in Evoke Pharma Inc (EVOK)
This table provides information about the institutional ownership of Evoke Pharma Inc (EVOK) during Q4 2022. The information is specifically focused on institutions that hold shares of Evoke Pharma Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
New Edge Advisors, LLC
New Orleans, LA |
BUY
|
- |
208New |
$300 - $557
|
208
$97.8
|
|
|
Feb 10, 2023
Q4 2022
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
BUY
|
- |
32New |
$46.1 - $85.8
|
32
$15
|
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
22New |
$31.7 - $59
|
22
$10.3
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
6+ 600.0% |
$8.64 - $16.1
|
7
$3.29
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Jan 24, 2023
Q4 2022
|
Harbor Investment Advisory, LLC
|
SELL
|
- |
-83Closed |
$120 - $222
|
0
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-185- 2.32% |
$266 - $496
|
7.79K
$3.66K
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.4K- 62.06% |
$2.01K - $3.74K
|
853
$401
|